Differential Kinase Activation in Peripheral Blood Mononuclear Cells from Non-Small-Cell Lung Cancer Patients Treated with Nivolumab

In the era of precision medicine, research of biomarkers for identification of responders to nivolumab therapy is a major challenge. Peripheral blood mononuclear cells (PBMC) could be an interesting surrogate tissue for identifying pharmacodynamic biomarkers. The aim of this exploratory study was to...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancers (Basel)
Main Authors: Noé, Gaëlle, Bellesoeur, Audrey, Golmard, Lisa, Thomas-Schoemann, Audrey, Boudou-Rouquette, Pascaline, Tiako Meyo, Manuela, Puszkiel, Alicja, Arrondeau, Jennifer, Alexandre, Jérome, Goldwasser, François, Blanchet, Benoit, Vidal, Michel
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628172/
https://ncbi.nlm.nih.gov/pubmed/31159331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11060762
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares